China Universal Asset Management Co., Ltd.

Position in DSGN — Design Therapeutics, Inc.

CIK 1906594 SHANGHAI, F4

Position in DSGN

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$1,301,431

+$927,872 QoQ

Shares Held

89,940

+156.2% QoQ

Ownership

0.144%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

of 17 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

China Universal Asset Management Co., Ltd. holds $180,189,557 across 240 Biotechnology names. DSGN ranks #35 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	48,265	$23,974,673
2	REGN	Regeneron Pharmaceuticals, Inc.	19,498	$12,157,782
3	ALNY	Alnylam Pharmaceuticals, Inc.	25,269	$7,606,727
4	RPRX	Royalty Pharma plc	120,547	$6,759,070
5	RVMD	Revolution Medicines, Inc.	33,835	$6,336,618
6	IONS	Ionis Pharmaceuticals Inc	76,302	$6,049,985
7	MRNA	Moderna, Inc.	63,149	$4,422,324
8	ARGX	Argenx SE	4,642	$4,306,708

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,301,431	89,940	+156.2%	Shares	Sole	2026-07-24
2026-03-31	$373,559	35,109	+2.4%	Shares	Sole	2026-04-28
2025-12-31	$321,565	34,282	-2.0%	Shares	Sole	2026-01-29
2025-09-30	$263,414	34,982	+206.8%	Shares	Sole	2025-11-10
2025-06-30	$38,424	11,402	+0.4%	Shares	Sole	2025-08-28
2025-03-31	$43,838	11,357	-5.4%	Shares	Sole	2025-04-30
2024-12-31	$74,077	12,006	+736.7%	Shares	Sole	2025-01-24
2023-09-30	$3,386	1,435	+95.8%	Shares	Sole	2024-05-22
2023-06-30	$4,617	733	-3.3%	Shares	Sole	2024-05-22
2023-03-31	$4,373	758	+33.5%	Shares	Sole	2024-05-22
2022-12-31	$5,827	568	+8.6%	Shares	Sole	2024-05-22
2022-09-30	$8,744	523	—	Shares	Sole	2022-10-21
No filing history on record for this holder in this stock.